Literature DB >> 1906811

Antithrombin Cambridge II, 384 Ala to Ser. Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins.

D J Perry1, M Daly, P L Harper, R C Tait, J Price, I D Walker, R W Carrell.   

Abstract

Four unrelated individuals have been identified with an identical antithrombin variant, associated in one of them with episodes of recurrent venous thromboses. In each case, the plasma antithrombin concentration was normal and the only function abnormality was a minor but consistent decrease in the heparin-induced thrombin inhibition suggesting a mutation at or near the reactive centre of the molecule. Amplification and direct sequencing of exon 6 showed a G----T mutation at nucleotide 1246, which corresponds to a substitution of a serine for an alanine at residue 384. This is one of a series of conserved alanines that form the stalk to the reactive centre loop. The observed changes in this variant are compatible with recent structural studies that infer that mobility of this stalk with partial re-entry into the A-sheet of the molecule is necessary for optimal inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906811     DOI: 10.1016/0014-5793(91)80809-h

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Carrier frequencies of antithrombin, protein C, and protein S deficiency variants estimated using a public database and expression experiments.

Authors:  Keiko Maruyama; Koichi Kokame
Journal:  Res Pract Thromb Haemost       Date:  2020-11-27

3.  Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics.

Authors:  Sara Reda; Jens Müller; Anna Pavlova; Behnaz Pezeshkpoor; Johannes Oldenburg; Bernd Pötzsch; Heiko Rühl
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.